| Recruiting | 3 | 2200 | Europe | Goserelin, Zoladex, Estradiol, FemSeven | University College, London, Medical Research Council | Anemia, Cardiovascular Complications, Hot Flashes, Osteoporosis, Prostate Cancer | 08/21 | 08/21 | | |
NCT02375204: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors |
|
|
| Active, not recruiting | 3 | 420 | Europe, US, RoW | paclitaxel, Taxol, ifosfamide, Ifex®, IFOS, cisplatin, CDDP, pegylated G-CSF, G-CSF, carboplatin, Paraplatin®, CBDCA, etoposide phosphate, VePesid®, Toposar®, VP16, stem cell reinfusion | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), European Organisation for Research and Treatment of Cancer - EORTC, Movember Foundation, Institute of Cancer Research (ICR), United Kingdom, Cancer Research UK, UNICANCER, Irish Group CTI | Germ Cell Tumor, Teratoma, Choriocarcinoma, Germinoma, Mixed Germ Cell Tumor, Yolk Sac Tumor, Childhood Teratoma, Malignant Germ Cell Neoplasm, Extragonadal Seminoma, Non-seminomatous Germ Cell Tumor, Seminoma | 06/31 | 06/31 | | |
| Active, not recruiting | 2 | 64 | Europe | Standard planning radiotherapy, Adaptive planning radiotherapy | Institute of Cancer Research, United Kingdom, Cancer Research UK | Bladder Cancer | 07/17 | 01/25 | | |
